Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1477-1486

  Yeung, Raymond S ^a,c   Katsetos, Christos D ^b   Klein Szanto, Andres ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA; AUTOSOMAL DOMINANT DISORDER; CEREBROSPINAL FLUID FLOW; CONTROLLED STUDY; GENETIC LINKAGE; GIANT CELL; HAMARTOMA; MENTAL DEFICIENCY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RAT; SUBEPENDYMOMA; TUBEROUS SCLEROSIS;

ANIMALS; ASTROCYTES; BRAIN DISEASES; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DISEASE MODELS, ANIMAL; EPENDYMA; GLIAL FIBRILLARY ACIDIC PROTEIN; HAMARTOMA; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MYELIN BASIC PROTEINS; NEUROFILAMENT PROTEINS; RATS; RATS, INBRED F344; RODENT DISEASES; TUBEROUS SCLEROSIS; TUBULIN;

EID: 0030663268     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gomez MR: In Tuberous Sclerosis, ed 2. New York, Raven Press, 1988
2. Curatolo P, Cusmai R, Cortesi F, Chiron C, Jambaque I, Dulac O: Neuropsychiatric aspects of tuberous sclerosis. Ann NY Acad Sci 1991, 615:8-16
3. Shepherd CW, Gomez MR: Mortality in the Mayo Clinic tuberous sclerosis complex study. Ann NY Acad Sci 1991, 615:375-377
4. Povey S, Burley MW, Attwood J, Benham F, Hunt D, Jeremiah SJ, Franklin D, Gillett G, Malas S, Robson EB, Tippett P, Edwards JH, Kwiatkowski DJ, Super M, Mueller R, Fryer A, Clarke A, Webb D, Osborne J: Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet 1994, 58:107-127
5. The European Chromosome 16 Tuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315
6. Wienecke R, Konig A, DeClue JE: Identification of tuberin, the tuberous sclerosis-2 product: tuberin possesses specific Rap 1GAP activity. J Biol Chem 1995, 270:16409-16414
7. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS: The tuberous sclerosis-2 gene product, tuberin, functions as a Rab5GAP in modulating endocytosis. J Biol Chem 1997, 272:6097-6100
8. Green AJ, Smith M, Yates JRW: Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet 1994, 6:193-196
9. Carbonara C, Longa L, Grosso E, Mazzucco G, Borrone C, Carre ML, Brisigotti M, Filippi G, Scabar A, Giannotti A, Falzone P, Monga G, Garini G, Gabrielli M, Riegler P, Danesion C, Ruggieri M, Magro G, Migone N: Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Gene Chrom Cancer 1996, 15:18-25
10. Eker R, Mossige J, Johannessen JV, Aars H: Hereditary renal adenomas and adenocarcinomas in rats. Diag Histopath 1981, 4:99-110
11. Yeung RS, Xiao G-H, Jin F, Lee W-C, Testa JR, Knudson AG: Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 1994, 91:11413-11416
12. Kobayashi T, Hirayama Y, Kobayash, E, Kubo Y, Hino O: A germline insertion in the tuberous sclerosis (TSC2) gene gives nse to the Eker rat model of dominantly inherited cancer. Nature Genet 1995, 9: 70-74
13. Xiao G-H, Jin F, Yeung RS: Germ-line TSC2 mutation in a dominantly inherited cancer model defines a novel family of rat intracisternal-A particle elements. Oncogene 1995, 11:81-87
14. Yeung RS, Xiao GH, Everitt J, Jin F, Walker C: Allelic Loss at the tuberous sclerosis 2 locus in spontaneous tumors of the Eker rat. Mol Carcinogen 1995, 14:28-36
15. Jin F, Wienecke R, Xiao G-H, Maize JC, DeClue JE, Yeung RS: Suppression of tumongenicity by the wild-type tuberous sclerosis 2 (TSC2) gene, and its C-terminal region. Proc Natl Acad Sci USA 1996, 93:9154-9159
16. Katsetos CD, Herman MM, Frankfurter A, Gass P, Walker CC, Collins VP, Barnard RO, Rubinstein LJ: Cerebellar desmoplastic medulloblastomas: a further immunohistochemical characterization of the reticulin-free pale islands. Arch Pathol Lab Med 1989, 113: 1019-1029
17. Walsh P, Metzger D, Higuchi R: Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991, 10:506-513
18. FASEB: Pathology of laboratory mice and rats. McLean, Virginia, Pergamon Infoline Inc, 1985
19. Wienecke R, Maize JC, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Resau JH, deGunzburg J, Yeung RS, DeClue JE: Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 1996, 13:913-923
20. DeClue JE, Papageorge AG, Fleteher JA, Diehl SR, Ratner N, Vass WC, Lowy DR: Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (Type 1) neurofibromatosis. Cell 1992, 69:265-273
21. Yoshida Y, Kawata M, Miura Y, Musha T, Sasaki T, Kikuch, A, Takai Y: Microinjection of smg/rap1/Krev1 p21 into Swiss 3T3 cells induces DNA synthesis, and morphological changes. Mol Cell Biol 1992, 12:3407-3414
22. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M: A ras-related gene with transformation suppressor activity. Cell 1989, 56:77-84
23. Kerfoot C, Wienecke R, Menchine R, Emelin J, Maize JC, Welsh CT, Norman MG, DeClue JE, Vinters HV: Localization of tuberous sclerosis 2 mRNA, and its protein product tuberin in human brain, and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol 1996, 6:367-377
24. Bender BL, Yunis EJ: Central nervous system pathology in tuberous sclerosis in children. Ultrastructural Pathol 1980, 1:287-299
25. Bonnin JM, Rubinstein LJ, Papasozomenos SCh, Marangos PJ: Subependymal giant cell astrocytoma: significance and possible cytogenetic implications of an immunohistochemical study. Acta Neuropathol 1984, 62:185-193
26. Chou TM, Chou SM: Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry of the CNS. Clin Neuropathol 1989, 8:45-52
27. Hirose T, Scheithauer BW, Lopes MBS, Gerber HA, Altermatt HJ, Hukee MJ, Vanden Berg SR, Charlesworth JC: Tuber, and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Acta Neuropathol 1995, 90:387-399
28. Lopes MBS, Frankfurter A, Zientek GM, Herman MM: The presence of neuron-associated microtubule proteins in the human U-251 MG cell line. Mol Chem Neuropathol 1992, 17:273-287
29. Zientek GM, Herman MM, Katsetos CD, Frankfurter A: Absence of neuron-associated microtubule proteins in the rat C-6 glioma cell line: a comparative immunoblot and immunohistochemical study. Neuropathol Appl Neurobiol 1993, 19:346-349
30. Franke FE, Schachenmayr W, Osborn M, Altmannsberger M: Unexpected immunoreactivities of intermediate filament antibody in human brain and brain tumors. Am J Pathol 1991, 139:67-79
31. Lin RCS, Matesic DF: Immunohistochemical demonstration of neuron-specific enolase, and microtubule-associated protein 2 in reactive astrocytes after injury in the adult forebrain. Neuroscience 1994, 60:11-16.
32. Cheng B, Christakos S, Mattson MP: Tumor necrosis factors protect neurons against metabolic-excitotoxic insults, and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153
33. Sima AAF, Robertson DM: Subependymal giant cell astrcytoma: case report with ultrastructural study. J Neurosurg 1979, 50:240-248
34. Celio M: Calbindin-D28k, and parvalbumin in the rat nervous system. Neuroscience 1990, 35:375-475
35. Katsetos CD, Frankfurter A, Christakos S, Mancall EL, Vlachos IN, Urich H: Differential localization of class III β-tubulin, and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex. J Neuropathol Exp Neurol 1993, 52:655-666
36. Katsetos CD, Burger PC: Medulloblastoma. Semin Diagn Pathol 1994, 11:85-97
37. Katsetos CD, Herman MM, Krishna L, Vender J, Vinores SA, Agamanolis DP, Schiffer D, Burger PC, Urich H: Calbindin-D28k in medulloblastoma subsets, and in the human medulloblastoma cell line D283. Med Arch Pathol Lab Med 1995, 119:735-743
38. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold M, van Slegtenhorst M, Welsh CT, Kwiatkowski J: Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996, 59:400-406
39. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J: Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc Natl Acad Sci USA 1996, 93:14152-14157
40. Sternberger LA, Sternberger NH: Monoclonal antibodies distinguish phosphorylated, and non-phosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 1983, 80:6126-6130